+ All Categories
Home > Documents > Soundbites

Soundbites

Date post: 30-Dec-2016
Category:
Upload: buithien
View: 217 times
Download: 0 times
Share this document with a friend
1
A RECENTLY discovered class of immune cell may hold the key to new treatments for asthma – and explain why existing therapies sometimes fail. Asthma occurs when immune cells go into overdrive and release inflammatory chemicals called cytokines. These cause excess production of mucus, which plugs up the lungs. The disease is generally associated with immune cells called T-helper 2 (TH2) cells and the cytokines they release, but their response alone is not enough to trigger asthma. Natural killer T (NKT) cells produce some of the same cytokines as TH2s, but release them faster and in greater quantities (see Diagram). NKT cells are hybrids: they kill invading microbes, like natural killer immune cells, but they also bind to antigens – foreign substances that trigger an immune response – like T-cells do. Last year, Omid Akbari and his colleagues at Children’s Hospital Boston, Massachusetts, discovered high numbers of NKT cells in the lungs of people with severe asthma, but virtually none in the lungs of healthy people. Meanwhile, separate studies in mice have shown NKT cell activation alone is enough to trigger asthma, prompting researchers to speculate that NKT cells might be equally, or more, important than TH2 cells in the development of the disease. Akbari’s team has now used a drug called DPPE-PEG to inhibit the action of NKT cells in mice and found that it prevented the type of asthma linked to allergies. DPPE- PEG already has approval from the US Food and Drug Administration, so clinical trials could begin as early as this year, says Akbari, who presented his findings at a meeting of the American Academy of Asthma, Allergy and Immunology in San Diego, California, this week. The findings may help explain why some people with asthma are resistant to conventional drugs such as corticosteroids. These inhibit many immune cells, but do not work on NKT cells, Akbari says. However, while DPPE-PEG shows promise, more work is needed to understand the role of NKT cells in asthma. For a start, they seem to bind to glycolipids – molecules made from fats and sugars – rather than the protein antigens recognised by most immune cells. Few glycolipid antigens have been discovered so far, although some have now been identified in bacteria and pollen. In the case of DPPE-PEG, Akbari believes it works by blocking the antigen receptors on NKT cells and so preventing their immune response. But since the allergen his team used to trigger asthma in the mice was an egg protein, it is unlikely to have been this that stimulated the NKT cells in the first place. It could be that protein allergens trigger the release of naturally occurring glycolipids by some as yet unidentified mechanism, which then stimulate NKT cells, suggests Akbari. “It is also possible that there’s a bacterial component to asthma,” says Mitchell Kronenberg, president of the La Jolla Institute of Allergy and Immunology in California. He suggests that bacteria present in the body may produce glycolipids that prime NKT cells to respond when an allergen is introduced. SOUNDBITES ‹ Talk with the patient while you are restraining him. Explain what you are doing and that you are using a restraint to ensure that he is safe.› NASA instructions for restraining a psychotic or suicidal fellow astronaut using duct tape, bungee cords and tranquillisers (AP, 24 February) ‹ We knew that we’d lost the war. Our psychological state was very strange by then. In those conditions, we could do anything, absolutely anything.› Akira Makino, a former medical auxiliary in the Japanese navy, breaks a 60-year silence to describe how he performed medical vivisection on prisoners of war in the Philippines (The Times, London, 26 February) ‹ This is one baby that clearly has come in from the cold.› Michael Chapman of the Sydney clinic IVF Australia, commenting on a baby born last year after a woman’s frozen egg and a donor’s frozen sperm created an embryo that was then frozen. Chapman believes the case is a first (The Sydney Morning Herald, 27 February) ‹ The message to men is: ‘Wake up and smell the java – it’s not just about women any more, it’s about you too’.› Pamela Madsen, executive director of the American Fertility Association, a national education and advocacy group, alerts men to mounting evidence that they too have a biological clock (The New York Times, 27 February) ‹ The electronic signals resemble the signals generated by the brain that control body movement.› Su Xuecheng of Shandong University of Science and Technology, China, on a pigeon with electrodes implanted in its brain that allow him to control its flight (Xinhua news agency, 27 February) ARIA PEARSON www.newscientist.com 3 March 2007 | NewScientist | 13 The essential tool for writing your research papers www. endnote.co.uk T: 01462 480055 E: [email protected] NEW VERSION JUST RELEASED! Asthma linked to hybrid immune cell Bronchial tube in run-up to an asthma atttack NKT cells release cytokines in response to allergens, triggering inflammation. The air passages become inflamed and mucus-filled Inflamed bronchial tube during an attack ANOTHER ROUTE TO ASTHMA NKT cell Mucus Cytokines
Transcript
Page 1: Soundbites

A RECENTLY discovered class of

immune cell may hold the key

to new treatments for asthma –

and explain why existing

therapies sometimes fail.

Asthma occurs when immune

cells go into overdrive and release

inflammatory chemicals called

cytokines. These cause excess

production of mucus, which

plugs up the lungs. The disease

is generally associated with

immune cells called T-helper 2

(TH2) cells and the cytokines they

release, but their response alone

is not enough to trigger asthma.

Natural killer T (NKT) cells

produce some of the same

cytokines as TH2s, but release

them faster and in greater

quantities (see Diagram).

NKT cells are hybrids: they kill

invading microbes, like natural

killer immune cells, but they

also bind to antigens – foreign

substances that trigger an immune

response – like T-cells do.

Last year, Omid Akbari and

his colleagues at Children’s

Hospital Boston, Massachusetts,

discovered high numbers of NKT

cells in the lungs of people with

severe asthma, but virtually none

in the lungs of healthy people.

Meanwhile, separate studies in

mice have shown NKT cell

activation alone is enough to

trigger asthma, prompting

researchers to speculate that NKT

cells might be equally, or more,

important than TH2 cells in the

development of the disease.

Akbari’s team has now used a

drug called DPPE-PEG to inhibit

the action of NKT cells in mice and

found that it prevented the type of

asthma linked to allergies. DPPE-

PEG already has approval from the

US Food and Drug Administration,

so clinical trials could begin as

early as this year, says Akbari,

who presented his findings at a

meeting of the American

Academy of Asthma, Allergy and

Immunology in San Diego,

California, this week.

The findings may help explain

why some people with asthma are

resistant to conventional drugs

such as corticosteroids. These

inhibit many immune cells, but do

not work on NKT cells, Akbari says.

However, while DPPE-PEG

shows promise, more work is

needed to understand the role of

NKT cells in asthma. For a start,

they seem to bind to glycolipids –

molecules made from fats and

sugars – rather than the protein

antigens recognised by most

immune cells. Few glycolipid

antigens have been discovered so

far, although some have now been

identified in bacteria and pollen.

In the case of DPPE-PEG, Akbari

believes it works by blocking the

antigen receptors on NKT cells

and so preventing their immune

response. But since the allergen

his team used to trigger asthma

in the mice was an egg protein,

it is unlikely to have been this that

stimulated the NKT cells in the

first place. It could be that protein

allergens trigger the release of

naturally occurring glycolipids

by some as yet unidentified

mechanism, which then stimulate

NKT cells, suggests Akbari.

“It is also possible that there’s a

bacterial component to asthma,”

says Mitchell Kronenberg,

president of the La Jolla Institute

of Allergy and Immunology in

California. He suggests that

bacteria present in the body may

produce glycolipids that prime

NKT cells to respond when an

allergen is introduced. �

SOUNDBITES

‹ Talk with the patient while you are restraining him. Explain what you are doing and that you are using a restraint to ensure that he is safe.›

NASA instructions for restraining a

psychotic or suicidal fellow astronaut

using duct tape, bungee cords and

tranquillisers (AP, 24 February)

‹ We knew that we’d lost the war. Our psychological state was very strange by then. In those conditions, we could do anything, absolutely anything.›

Akira Makino, a former medical

auxiliary in the Japanese navy,

breaks a 60-year silence to describe

how he performed medical vivisection

on prisoners of war in the Philippines

(The Times, London, 26 February)

‹ This is one baby that clearly has come in from the cold.›

Michael Chapman of the Sydney clinic

IVF Australia, commenting on a baby

born last year after a woman’s frozen

egg and a donor’s frozen sperm created

an embryo that was then frozen.

Chapman believes the case is a first

(The Sydney Morning Herald, 27 February)

‹ The message to men is: ‘Wake up and smell the java – it’s not just about women any more, it’s about you too’.›

Pamela Madsen, executive director

of the American Fertility Association,

a national education and advocacy

group, alerts men to mounting

evidence that they too have a biological

clock (The New York Times, 27 February)

‹ The electronic signals resemble the signals generated by the brain that control body movement.›

Su Xuecheng of Shandong University

of Science and Technology, China, on a

pigeon with electrodes implanted in its

brain that allow him to control its flight

(Xinhua news agency, 27 February)

ARIA PEARSON

www.newscientist.com 3 March 2007 | NewScientist | 13

The essentialtool for writingyour research

paperswww.endnote.co.uk

T: 01462 480055 E: [email protected]

NEW VERSION JUST RELEASED!

Asthma linked to hybrid immune cell

Bronchial tube in run-up

to an asthma atttack

NKT cells release cytokines in

response to allergens, triggering

inflammation. The air passages

become inflamed and mucus-filled

Inflamed bronchial tube

during an attack

ANOTHER ROUTE TO ASTHMA

NKT cell

Mucus

Cytokines

070303_N_p12_p13.indd 13070303_N_p12_p13.indd 13 27/2/07 4:59:14 pm27/2/07 4:59:14 pm

Recommended